MA28078A1 - Produits pharmaceutiques contenant des bisphosphonates - Google Patents
Produits pharmaceutiques contenant des bisphosphonatesInfo
- Publication number
- MA28078A1 MA28078A1 MA28895A MA28895A MA28078A1 MA 28078 A1 MA28078 A1 MA 28078A1 MA 28895 A MA28895 A MA 28895A MA 28895 A MA28895 A MA 28895A MA 28078 A1 MA28078 A1 MA 28078A1
- Authority
- MA
- Morocco
- Prior art keywords
- products containing
- pharmaceutical products
- containing bisphosphonates
- bisphosphonates
- pharmaceutical
- Prior art date
Links
- 229940122361 Bisphosphonate Drugs 0.000 title 1
- 150000004663 bisphosphonates Chemical class 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940127557 pharmaceutical product Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50440203P | 2003-09-18 | 2003-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA28078A1 true MA28078A1 (fr) | 2006-08-01 |
Family
ID=34312464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28895A MA28078A1 (fr) | 2003-09-18 | 2006-03-27 | Produits pharmaceutiques contenant des bisphosphonates |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7932241B2 (enExample) |
| EP (1) | EP1663314A2 (enExample) |
| JP (1) | JP4802096B2 (enExample) |
| KR (1) | KR101015718B1 (enExample) |
| CN (1) | CN1852739A (enExample) |
| AR (1) | AR045670A1 (enExample) |
| AU (1) | AU2004271731B2 (enExample) |
| BR (1) | BRPI0414562A (enExample) |
| CA (1) | CA2536206C (enExample) |
| CO (1) | CO5680461A2 (enExample) |
| EC (1) | ECSP066419A (enExample) |
| IL (1) | IL173766A (enExample) |
| IS (1) | IS8351A (enExample) |
| MA (1) | MA28078A1 (enExample) |
| MY (1) | MY141763A (enExample) |
| NO (1) | NO20061682L (enExample) |
| NZ (1) | NZ545343A (enExample) |
| PE (1) | PE20050468A1 (enExample) |
| RU (1) | RU2358739C2 (enExample) |
| TN (1) | TNSN06084A1 (enExample) |
| TW (1) | TWI345977B (enExample) |
| WO (1) | WO2005025551A2 (enExample) |
| ZA (1) | ZA200601209B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050119230A1 (en) * | 2003-09-18 | 2005-06-02 | Alexandra Glausch | Pharmaceutical products comprising bisphosphonated |
| MY141763A (en) | 2003-09-18 | 2010-06-30 | Novartis Ag | Pharmaceutical products comprising bisphosphonates |
| EP1923049A1 (en) * | 2006-11-17 | 2008-05-21 | Besins Healthcare | Pharmaceutical compositions comprising a bisphosphonate compound |
| WO2008059060A1 (en) * | 2006-11-17 | 2008-05-22 | Besins Healthcare | Liquid pharmaceutical compositions comprising a bisphosphonate compound |
| SI3345607T1 (sl) * | 2006-12-29 | 2023-03-31 | Ossifi-Mab Llc | Postopki spreminjanja rasti kosti z dajanjem antagonista ali agonista SOST ali WISE |
| JP5607408B2 (ja) * | 2009-04-03 | 2014-10-15 | 帝人ファーマ株式会社 | アレンドロン酸含有注射剤 |
| US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| KR101813728B1 (ko) * | 2009-07-31 | 2017-12-29 | 그뤼넨탈 게엠베하 | 결정화 방법 및 생체이용률 |
| US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| US8882740B2 (en) * | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
| EP2363111A1 (en) | 2010-03-01 | 2011-09-07 | Combino Pharm, S.L. | Stable pharmaceutical composition comprising bisphosphonate |
| WO2011132826A1 (en) * | 2010-04-19 | 2011-10-27 | Snu R&Db Foundation | Transdermal drug delivery system and pharmaceutical composition for preventing or treating bone diseases |
| WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
| EP2712611A1 (en) * | 2012-09-27 | 2014-04-02 | B. Braun Melsungen AG | Stabilized aqueous compositions of neuromuscular blocking agents |
| RU2506085C1 (ru) * | 2013-01-30 | 2014-02-10 | Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") | Тетраэтил-2-(2,2,6,6-тетраметилпиперидин-4-иламино)-этилен-1,1-бисфосфонат, обладающий противоопухолевой активностью |
| CN104721132B (zh) * | 2013-12-21 | 2018-05-18 | 石药集团恩必普药业有限公司 | 一种唑来膦酸注射液及其制备方法 |
| US10098813B2 (en) | 2014-09-03 | 2018-10-16 | Sun Pharmaceutical Industries Limited | Perfusion dosage form |
| GB201505347D0 (en) * | 2015-03-27 | 2015-05-13 | Salupont Consulting Ltd | Sterilisation of s-nitrosothiols |
| CN108261393B (zh) * | 2015-09-27 | 2020-10-27 | 山东则正医药技术有限公司 | 一种含有唑来膦酸的注射用药物组合物 |
| CN109069342A (zh) | 2016-02-09 | 2018-12-21 | 太阳医药工业有限公司 | 灌注系统 |
| WO2017208070A1 (en) | 2016-05-31 | 2017-12-07 | Grünenthal GmbH | Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis |
| WO2019067145A1 (en) * | 2017-08-28 | 2019-04-04 | Asdera Llc | USE OF CYCLODEXTRINS IN DISEASES AND DISORDERS INVOLVING PHOSPHOLIPID DISRUPTION |
| JP2020535235A (ja) * | 2017-09-28 | 2020-12-03 | アスデラ エルエルシー | リン脂質の調節異常が関与する疾患および障害におけるシクロデキストリンの使用 |
| CN110161168B (zh) * | 2018-02-12 | 2022-12-20 | 四川科伦药物研究院有限公司 | 唑来膦酸及其杂质的高效液相色谱检测方法 |
| MX2022002980A (es) | 2019-09-16 | 2022-04-06 | Amgen Inc | Metodo para la esterilizacion externa de un dispositivo de suministro de farmacos. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2038692T4 (es) * | 1986-11-21 | 2012-02-10 | Novartis Ag | Procedimiento para la obtencion de acidos alcanodifosfonicos substituidos. |
| JP3672342B2 (ja) * | 1994-09-26 | 2005-07-20 | アステラス製薬株式会社 | ビスホスホン酸又はその誘導体を含有する注射液とその安定化方法、及び注射液アンプル |
| FR2740686B1 (fr) * | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
| GB0012209D0 (en) * | 2000-05-19 | 2000-07-12 | Novartis Ag | Organic compounds |
| AU2001293473A1 (en) * | 2000-09-18 | 2002-03-26 | Mayne Pharma International Pty Ltd | Diphosphonate solutions |
| EE200300477A (et) | 2001-05-02 | 2003-12-15 | Sicor, Inc. | Süstitav pamidronaatdinaatrium |
| CA2372450A1 (en) * | 2001-05-10 | 2001-09-19 | Pharmaceutical Partners Of Canada Inc. | Liquid injectable formulation of disodium pamidronate |
| MY141763A (en) | 2003-09-18 | 2010-06-30 | Novartis Ag | Pharmaceutical products comprising bisphosphonates |
-
2004
- 2004-09-15 MY MYPI20043727A patent/MY141763A/en unknown
- 2004-09-16 AR ARP040103333A patent/AR045670A1/es unknown
- 2004-09-16 PE PE2004000900A patent/PE20050468A1/es not_active Application Discontinuation
- 2004-09-17 KR KR1020067005455A patent/KR101015718B1/ko not_active Expired - Fee Related
- 2004-09-17 CN CNA2004800269883A patent/CN1852739A/zh active Pending
- 2004-09-17 WO PCT/EP2004/010470 patent/WO2005025551A2/en not_active Ceased
- 2004-09-17 EP EP04765362A patent/EP1663314A2/en not_active Ceased
- 2004-09-17 TW TW093128260A patent/TWI345977B/zh not_active IP Right Cessation
- 2004-09-17 CA CA2536206A patent/CA2536206C/en not_active Expired - Fee Related
- 2004-09-17 NZ NZ545343A patent/NZ545343A/en not_active IP Right Cessation
- 2004-09-17 AU AU2004271731A patent/AU2004271731B2/en not_active Ceased
- 2004-09-17 BR BRPI0414562-3A patent/BRPI0414562A/pt not_active Application Discontinuation
- 2004-09-17 RU RU2006112596/15A patent/RU2358739C2/ru not_active IP Right Cessation
- 2004-09-17 US US10/570,339 patent/US7932241B2/en not_active Expired - Fee Related
- 2004-09-17 JP JP2006526598A patent/JP4802096B2/ja not_active Expired - Lifetime
-
2006
- 2006-02-10 ZA ZA200601209A patent/ZA200601209B/en unknown
- 2006-02-16 IL IL173766A patent/IL173766A/en not_active IP Right Cessation
- 2006-03-13 IS IS8351A patent/IS8351A/is unknown
- 2006-03-13 EC EC2006006419A patent/ECSP066419A/es unknown
- 2006-03-17 TN TNP2006000084A patent/TNSN06084A1/en unknown
- 2006-03-21 CO CO06027690A patent/CO5680461A2/es unknown
- 2006-03-27 MA MA28895A patent/MA28078A1/fr unknown
- 2006-04-12 NO NO20061682A patent/NO20061682L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7932241B2 (en) | 2011-04-26 |
| CA2536206A1 (en) | 2005-03-24 |
| KR101015718B1 (ko) | 2011-02-22 |
| EP1663314A2 (en) | 2006-06-07 |
| PE20050468A1 (es) | 2005-10-03 |
| TNSN06084A1 (en) | 2007-10-03 |
| BRPI0414562A (pt) | 2006-11-07 |
| ECSP066419A (es) | 2006-09-18 |
| WO2005025551A2 (en) | 2005-03-24 |
| WO2005025551A3 (en) | 2006-01-12 |
| IL173766A (en) | 2012-10-31 |
| AU2004271731B2 (en) | 2008-07-24 |
| CN1852739A (zh) | 2006-10-25 |
| ZA200601209B (en) | 2007-04-25 |
| NO20061682L (no) | 2006-06-14 |
| KR20060087568A (ko) | 2006-08-02 |
| NZ545343A (en) | 2010-08-27 |
| JP4802096B2 (ja) | 2011-10-26 |
| RU2358739C2 (ru) | 2009-06-20 |
| IL173766A0 (en) | 2006-07-05 |
| MY141763A (en) | 2010-06-30 |
| JP2007505861A (ja) | 2007-03-15 |
| AR045670A1 (es) | 2005-11-02 |
| US20070015736A1 (en) | 2007-01-18 |
| TWI345977B (en) | 2011-08-01 |
| TW200522969A (en) | 2005-07-16 |
| IS8351A (is) | 2006-03-13 |
| CO5680461A2 (es) | 2006-09-29 |
| RU2006112596A (ru) | 2007-11-10 |
| CA2536206C (en) | 2010-08-24 |
| AU2004271731A1 (en) | 2005-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2838048B1 (fr) | Produit dentaire reticulable/dereticulable | |
| DK1620118T3 (da) | Reversible pegylerede lægemidler | |
| EP1615615A4 (en) | PHARMACEUTICAL PRODUCTS | |
| TWI345977B (en) | Pharmaceutical products comprising bisphosphonates | |
| EP1506786A4 (en) | MEDICAL GHRELIN CONTAINING COMPOSITIONS | |
| EP2018872A4 (en) | PHARMACEUTICAL PRODUCT | |
| CY2018005I2 (el) | Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης | |
| EP2205218A4 (en) | ESOMEPRAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION | |
| GB0312148D0 (en) | Stabilized pharmaceutical products | |
| EP1490023A4 (en) | DRUGS SIGNATURES | |
| EP1620066A4 (en) | ORAL CARE PROCESSES AND PRODUCTS | |
| GB0315889D0 (en) | Stable pharmaceutical products | |
| EP2063707A4 (en) | DISINFECTING AND HYGIENIZING AGENT FOR COSMETICS AND COSMETIC TOOLS | |
| EP1830831A4 (en) | PHARMACEUTICAL FORMULATIONS OF GALLIUM SALTS | |
| ITBO20030050A1 (it) | Macchina per il trattamento di prodotti farmaceutici. | |
| FR2855825B1 (fr) | Produits aryl-heteroaromatiques, compositions les contenant et utilisation | |
| EP1849774A4 (en) | CYCLOHEPTA (B) PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING THEREOF | |
| NO20034847D0 (no) | Munn-hygieneprodukt | |
| ITBO20030155A1 (it) | Macchina per l'estrazione di prodotti da blister. | |
| GB0316360D0 (en) | Pharmaceutical product | |
| GB0328040D0 (en) | Pharmaceutical uses of bisphosphonates | |
| FR2885770B1 (fr) | Nouvel ingredient alimentaire et produits le contenant | |
| FR2861373B1 (fr) | Distributeurs de produits semi-solides ou pateux | |
| FI20040148A7 (fi) | Lääkeannos- tai lääkevalmistetunnistin | |
| CA94788S (fr) | Distributeur de produits fluides |